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Sir, 
I would like to make a number of comments regarding 
the paper by Pellet al. 1 Adequately controlled studies 
assessing quality of life, in patients with intermittent 
claudication using validated questionnaires, are cer- 
tainly lacking. Two previously published series have, 
however, looked at this - -  Hunt et al. 2 did not look 
specifically at claudicants and Arfvidsson et al. 3 
although they studied claudicants and linked quality 
of life with mobilit~ used historical data from a group 
of women as controls. 
The authors do not mention if the stopping distance 
was measured on a treadmill or obtained from the 
patient's history - -  patients are unreliable in this 
respect. Stopping distance is moreover a highly 
subjective measure and not an accurate indicator of 
disease severity. Furthermore, the definition of inter- 
mittent claudication does not mention a specific 
distance and by using a cut-off of 200m the authors are 
imposing a selection bias. 
The results of the SF-36 in this series are compared 
to normative data published 2years previously from a 
different population (Oxford) and of a different age 
group (18-64 years compared to the claudicants who 
are 36-87 years old). Does this really constitute a valid 
control group? 
The authors have not considered the impact of 
associated illnesses on quality of life in the claudi- 
cants. I have carried out a similar project using the 
Nottingham Health Profile (admittedly not as sensi- 
tive as the SF-36 for lesser degrees of disability) to 
assess quality of life in claudicants and a control 
group 4 and shown that additional disorders have a 
considerable impact on quality of life. 
It has been previously shown that there is disparity 
in patients' and clinicians' judgements of quality of 
life. 5"6 The results from Pe l le t  aI. support this 
conclusion, but it is interesting that patients tended to 
rate their quality of life higher than the surgeon. A 
recent leader by some of the surgeons involved in this 
paper stated that reconstructive surgery has not been 
widely applied to claudicants because the discomfort 
and restriction in lifestyle are not considered by 
clinicians to be severe enough to justify the surgical 
risks. 7 
Assessment of quality of life should be used in 
addition to morbidity and mortality in determining 
the outcome of various treatments. It may also help to 
justify the allocation of resources to various inter- 
ventions in claudicants - -  such as structured exercise 
programmes or percutaneous transluminal 
angioplasty. 
H. S. Khaira 
Sutton Coldfield, U.K. 
References 
1 PELL JP. Impact of intemittent claudication on quality of life. Eur 
] Vasc Endovasc Surg 1995; 9: 469-472. 
2 HUNT SN, McEwEN J, MCKENNA SP, BACKETT EM, POPE C. 
Subjective health of patients with peripheral vascular disease. 
Practitioner 1982; 226: 133-136. 
3 ARFVIDSSON B, KARLSSON J, DAHLLOF AG, LUNDHOLM K, SULLIVAN 
M. The impact of intermittent claudication on quality of life 
evaluated by the Sickness Impact Profile technique..Eur J Clin 
Invest 1993; 23: 741-745. 
4 KHAIRA HS, HANGER R, SHEARMAN CP. Quality of life in patients 
with intermittent claudication. Eur I Vasc Endovasc Surg (In 
press). 
5 SLEVIN ML, PLANT H, LYNCH D, DRINKWATER J, GREGORY 1vVlVI. 
Who should measure quality of life, the doctor or the patient? Br 
J Cancer 1988; 57: 109-112. 
6 PEARLMAN RA, UHLMANN RE. Quality of life in chronic diseases: 
Perceptions of elderly patients. Journal of Gerontology. Medical 
Sciences, 1988; 43: M25-M30. 
7 WHYMAN MR, RUCKLEY CV, FOWKES FGR. Angioplasty for mild 
intermittent claudication. Br J Surg 1991; 78: 643-645. 
Authors Reply 
Sir, 
As highlighted by Mr Khaira, previous tudies on the 
1078-5884/95/080510 + 02 $12.00/0 © 1995 W. B. Saunders Company Ltd. 
